post-exposure-prophylaxis

Documents about post-exposure-prophylaxis

• Doxy-Post-exposure Prophylaxis#1231687ClinicalTrials.gov
• Impact of Health Education on Knowledge, Attitude and Practice of Post-exposure Prophylaxis#1352488ClinicalTrials.gov
• Purified Rabies Vaccine for Human Use (Chick-embryo Cell)#969082ClinicalTrials.gov
• Knowledge- Attitude- Practice (KAP) of Post Exposure Prophylaxis for Fifth Year Dental Students of a Private Egyptian University#861623ClinicalTrials.gov
• Body Compartment Pharmacokinetics of Anti- Retroviral Agents That May be Used for Future HIV Post- Exposure Prophylaxis.#892074ClinicalTrials.gov
• EBOla Post-Exposure Prophylaxis#245567ClinicalTrials.gov
• Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT#332817ClinicalTrials.gov
• Guidelines for HIV post-exposure prophylaxis: web annex A: summaries of declarations of interest#286821WHO IRIS
• Non-Occupational HIV Post-Exposure Prophylaxis Update#393098Open Research
• Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules#1486411ClinicalTrials.gov
• Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients#896640ClinicalTrials.gov
• PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19#994204ClinicalTrials.gov
• HST for Female Sex Workers/Drug Users in Kazakhstan#839258ClinicalTrials.gov
• Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy#883891ClinicalTrials.gov
• Comparative Long-Term Immunogenicity and Boosting of 3-Session Versus 4-Session Intradermal Rabies Post-Exposure Prophylaxis Regimens in Cambodia and Madagascar: The RESIST-3 Study#1479869HAL (France)
• Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men.#981925ClinicalTrials.gov
• Protocol for a well-performed rabies post-exposure prophylaxis delivery: to read along with the decision trees 1- Wound risk assessment and 2 - PEP risk assessment#328618WHO IRIS
• Guideline on doxycycline post-exposure prophylaxis for sexually transmitted infections among men who have sex with men and transgender women#365977WHO IRIS
• Post-exposure prophylaxis with antibiotics to prevent sexually transmitted infections.#13719NCBI PubMed Central
• Study to Evaluate GR1801's Efficacy and Safety#424217ClinicalTrials.gov
• Postexposure prophylaxis for HIV among healthcare workers in Türkiye: a descriptive, multicenter retrospective study#348459Recep Tayyip Erdoğan University Institutional Repository
• Guideline on doxycycline post-exposure prophylaxis for sexually transmitted infections among men who...#369342World Health Organization
• Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection#831596ClinicalTrials.gov
• Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar#834740ClinicalTrials.gov
• Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis#1213097ClinicalTrials.gov
• Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies#160181ClinicalTrials.gov
• COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir#991911ClinicalTrials.gov
• Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)#1443431ClinicalTrials.gov
• Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19#1100841ClinicalTrials.gov
• Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19#253059ClinicalTrials.gov
• Rabies exposure in international travellers: Experience from a single travel clinic in Paris, France, 2018–2022#157695HAL (France)
• Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus#1349565ClinicalTrials.gov
• Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.#900060ClinicalTrials.gov
• A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.#1033455ClinicalTrials.gov
• Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)#1338549ClinicalTrials.gov
• Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection#1151562ClinicalTrials.gov
• Una revisión científica, histórica y reflexiva, sobre los 40 años del descubrimiento del virus de inmunodeficiencia humana#303785DIALNET OAI Articles
• A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes#967081ClinicalTrials.gov
• Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year#852835ClinicalTrials.gov
• Cost-effectiveness of providing pre-exposure and post-exposure prophylaxis for the prevention of HIV via online pharmacies in western Kenya: a modelling study.#441083PubMed
• Nationwide registry-based analysis of rabies exposures in Iran: Epidemiological patterns and post-exposure prophylaxis adherence.#1159039NCBI PubMed Central
• A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States#857681ClinicalTrials.gov
• Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19#1362452ClinicalTrials.gov
• Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)#830412ClinicalTrials.gov
• Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)#841561ClinicalTrials.gov
• Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis#907461ClinicalTrials.gov
• Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen#383601ClinicalTrials.gov
• Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen#861361ClinicalTrials.gov
• A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services#1421972ClinicalTrials.gov
• Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV#1059898ClinicalTrials.gov